NCT04398420

Transurethral Vapor Enucleation Resection of the Prostate (TVERP), Bipolar TURis and HoLEP

Safety and Efficacy of TVERP in BPH Patients With Prostate Size ˃30 and ≤80 ml: a Comparison Study Between TVERP With the Plasma Vaporisation Button, Bipolar TURis and HoLEP Treatments.

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 29 (actual)
• Sponsor: Olympus Surgical Technologies Europe · Industry
• Sex: Male
• Age: 22 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

To verify the safety and efficacy of the use of the plasma vaporisation button in Transurethral Vapor Enucleation and Resection of the prostate (TVERP) for treatment of Benign prostatic hypertrophy (BPH) patients with prostate ˃30 and ≤80 ml compare to TURis or HoLEP surgery methods.

Conditions

• Benign Prostatic Hypertrophy

Interventions

Type	Name	Description
DEVICE	TVERP	Transurethral Vapor Enucleation Resection of the prostate
DEVICE	TURis	Transurethral Vapor Enucleation Resection of the prostate
DEVICE	HoLEP	Transurethral Vapor Enucleation Resection of the prostate

Timeline

• Start date: 2020-08-27
• Primary completion: 2022-08-01
• Completion: 2022-08-01
• First posted: 2020-05-21
• Last updated: 2023-01-09

Locations

3 sites across 1 country: China